STOCK TITAN

NuSkin Enterprises (NUS) 10-K Filings

NUS NYSE

Here are the 10-K annual reports from NuSkin Enterprises, Inc. (NUS) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-K covers the audited annual report, with the full financial statements, so if you follow NUS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NUS filings page.

Rhea-AI Summary

Nu Skin Enterprises reported 2025 revenue of $1.485 billion, down from $1.732 billion in 2024 and $1.969 billion in 2023, reflecting pressure on its core direct-selling business. About 85% of 2025 revenue came from Nu Skin-branded operations and 15% from its Rhyz investment arm.

Beauty products generated $568.1 million (38% of sales) and wellness products $689.1 million (46%), with ageLOC lines contributing meaningful portions in both categories. Rhyz businesses produced $223.6 million, while one Rhyz unit, Mavely, was sold after contributing $69.6 million to 2024 revenue.

Customer, paid affiliate and sales leader counts declined across regions, including Mainland China, where a restrictive and evolving regulatory environment continues to create operational risk. The company highlights extensive global regulatory oversight of direct selling, cosmetics, supplements and devices, including heightened FTC scrutiny of multi-level marketing earnings claims and complex licensing rules in China.